
Singularity.AI is a venture-backed Medtech company founded in 2018, focused on delivering integrated workflow automation solutions for healthcare professionals. The company offers AI-driven pathology and biomarker services, enhancing drug development processes through advanced analytics and real-time project visibility. Their platform combines AI with human expertise to ensure regulatory compliance and result fidelity, making medical innovations accessible and efficient. With a unique Hardware-Enabled SaaS subscription model, Singularity.AI aims to empower life sciences and healthcare professionals to collaborate effectively and securely, ultimately accelerating medical innovation.

Singularity.AI is a venture-backed Medtech company founded in 2018, focused on delivering integrated workflow automation solutions for healthcare professionals. The company offers AI-driven pathology and biomarker services, enhancing drug development processes through advanced analytics and real-time project visibility. Their platform combines AI with human expertise to ensure regulatory compliance and result fidelity, making medical innovations accessible and efficient. With a unique Hardware-Enabled SaaS subscription model, Singularity.AI aims to empower life sciences and healthcare professionals to collaborate effectively and securely, ultimately accelerating medical innovation.
Founded: 2018
Headquarters: San Jose, California
Industry: Biotechnology / Medtech
Product focus: AI-enabled pathology platform + microscope-mounted smart camera hardware
Funding rounds: Seed (2018) and Convertible Note (2021)
Pathology workflow automation, medical image analysis, and biomarker services across translational research, preclinical, and clinical trial phases.
2018
Biotechnology
Investors include Plug and Play and Wisemont Capital
“Backed by early-stage investors including Oriza Ventures, Plug and Play, Social Starts, and Wisemont Capital”